Azabicyclic heterocycles as cannabinoid receptor modulators

The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combi...

Full description

Saved in:
Bibliographic Details
Main Authors SUN, CHONG-QING, WU, XIMAO, ELLSWORTH, BRUCE, EWING, WILLIAM R, GU, ZHENGXIANG, JOHNSON, STEPHEN R, YU, GUI-XUE, GERRITZ, SAMUEL W, WU, GANG, HUANG, YAN-TING, SHER, PHILIP M, PENDRI, ANNAPURNA, SITKOFF, DOREE F, WANG, YING, MIKKILINENI, AMARENDRA B, MURUGESAN, NATESAN
Format Patent
LanguageChinese
English
Published 01.09.2005
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula I. , including all prodrugs, pharmaceutically acceptable salts and stereoisomers, R1, R2, R3, R6, R7, m and n are described herein:
Bibliography:Application Number: TW200493138982